Exagen earnings were -$16.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest XGN earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$5.0M, up 69.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, XGN reported annual earnings of -$23.7M, with -50% growth.
On XGN's earnings call on Invalid Date, Exagen (NASDAQ: XGN) reported Q3 2024 earnings per share (EPS) of -$0.28, up 9.68% year over year. Total XGN earnings for the quarter were -$5.03 million. In the same quarter last year, Exagen's earnings per share (EPS) was -$0.31.
As of the last Exagen earnings report, Exagen is currently losing money. Exagen's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$16.93 million, a 47.87% decrease year over year.
What was XGN's earnings growth in the past year?
As of Exagen's earnings date in Invalid Date, Exagen's earnings has grown year over year. XGN earnings in the past year totalled -$16.93 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.